All News

The American Chemical Society (ACS) has announced Brian Bidlingmeyer of Agilent Technologies, Inc. (Santa Clara, California) and a member of LCGC's editorial advisory board to the 2012 class of ACS Fellows.

Figure3-806479-1408546143599.jpg

LCGC spoke to Martin Giera of Leiden University Medical Centre, Leiden, The Netherlands, about developments in biomarker discovery.

In a random study of drugs from 713 pharmacies from 19 countries, 9.1% of anti-tuberculosis drugs analysed failed basic quality control testing using thin layer chromatography (TLC) for the required level of active pharmaceutical ingredient (API), according to a recent study published in the International Journal of Tuberculosis and Lung Disease.1

BiotageLogo-805880-1408546769880.jpg

Biotage EVOLUTE® EXPRESS

The EVOLUTE? EXPRESS range of 96-well SPE plates combine powerful EVOLUTE sorbent chemistry with innovative features that enhance productivity by optimizing and even eliminating the need for some traditional SPE procedural steps.

Lisa Witte ? vice-president/general manager of Thermo Fisher Scientific?s portable analytical instruments business (California, USA) ? has received a Women in Manufacturing STEP (Science, Technology, Engineering and Production) award from the Manufacturing Institute/Deloitte, the University of Phoenix and the Society of Manufacturing Engineers.

The American Chemical Society (ACS) named Brian Bidlingmeyer of Agilent Technologies, Inc. (Santa Clara, California) and a member of LCGC?s editorial advisory board to the 2012 class of ACS Fellows.

Ship-805911-1408546744791.jpg

Tablets found aboard an ancient shipwreck could identify the early beginnings of medicine. A team of scientists led by Erika Ribechini of the University of Pisa (Pisa, Italy) determined the composition of tablets found aboard a ship-wrecked off the coast of Tuscany (Italy) around 2,000 years ago.1

When discussing optimization and improvements to costly and time-consuming purification processes "trapping" columns can be an alternative to fractionation.

snake-805910-1408546746392.jpg

Therapeutic poison

A team of scientists in Germany1 has identified a new protein from the venom of the snake, Vipera palaestinae, that could be used in the development of anti-cancer drugs.